18th Annual Symposium on Anti-Angiogenesis and Immune Therapies for Cancer 2016

Topics

• Stromal therapy and targets in the tumor microenvironment
• Rationale for and mechanisms of action of novel anti-angiogenic and immune-targeted strategies
• Controversies with the new therapeutics, mechanisms of resistance, unique adverse events, and ongoing clinical trials
• Combination regimens

sessions will include:

• Crosstalk in Tumor Immunology and Preclinical Modeling
• Basic Science: Update on Angiogenesis and Tumor Immunology
• Controversies with New Therapeutics Targeting Angiogenesis and Tumor Immunology
• Novel Approaches to Activate the Immune Response to Tumor Antigens
• Overview of Clinical Trials of AgentsTargeting Angiogenesis and Tumor Immunology: Clinical Trial Overview
• Biomarkers and Predictors of Response

Who should Attend

Clinicians, scientists, and other healthcare professionals who work in the area of tumor immunology.